NantHealth, Inc. (9)
Browse by Contract Category
Contracts
-
Form of Exchange Agreement by and between the Company and
(Filed With SEC on April 14, 2021)
-
Description of Securities
(Filed With SEC on February 26, 2021)
-
Form of Exchange Agreement by and between the Company and certain holders, dated as of April 1
(Filed With SEC on April 14, 2021)
-
Amended and Restated Promissory Note by and between the Company and Nant Capital, LLC dated as of December 31, 2020
(Filed With SEC on January 5, 2021)
-
Amendment No. 3 to Second Amended and Restated NantOmics Exclusive Reseller Agreement dated as of December 31, 2020
(Filed With SEC on January 5, 2021)
-
Open NMS Assignment Agreement, dated as of July 22, 2020, between the Registrant and Cambridge Equities, LP
(Filed With SEC on August 10, 2020)
-
Description of Securities
(Filed With SEC on February 28, 2020)
-
Asset Purchase Agreement dated as of January 13, 2020, among Masimo Corporation and VCCB Holdings, Inc., and NantHealth, Inc
(Filed With SEC on February 28, 2020)
-
Amendment no. 2 to Second Amended and Restated Nantomics Exclusive Reseller Agreement
(Filed With SEC on May 9, 2019)